glucagon
Search documents
Altimmune (NasdaqGM:ALT) 2025 Conference Transcript
2025-11-20 09:02
Altimmune (NasdaqGM:ALT) 2025 Conference November 20, 2025 03:00 AM ET Company ParticipantsVipin Garg - CEOChristophe Arbet-Engels - Chief Medical OfficerConference Call ParticipantsRoger Song - Senior AnalystRoger SongAll right. Good morning, everyone, to Jeffrey's London Healthcare Conference 2025. My name is Roger Song, one of the Senior Analysts covering SMID Cap Biotech in the U.S.. It is my great pleasure to have the next fireside chat with Altimmune, who have Vipin and then Christophe. Good to meet y ...